What is NTLA's dilution risk score?

NTLA has a latest available DilutionScore record of 54/100, categorized as high dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for NTLA, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for NTLA?

DilutionWatch tracks 25 SEC filing types for NTLA including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect NTLA shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For NTLA, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for NTLA tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for NTLA. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

NTLA Dilution Risk Score: 54/100 (HIGH)

Score Breakdown

📋 Offering Ability

46

💰 Cash Runway

65

📊 Float Risk

17

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

⛅

Watch

Minor dilution signals detected

model est. 16%

💰 Capital Raise model 33%

• Under 12 months cash (11mo)

• Active ATM program with $180M remaining capacity

🔔 Track NTLA — Get forecast alerts →

Market Data

Market Cap$1.97B

Shares Outstanding140.13M

Float134.16M

Cash$437.76M

Debt$80.49M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 23.8% shares (2026Q1 vs prior)

310 institutional holders · 137.81M shares

#1 ARK Investment Management LLC 14.51M shares

#2 BlackRock, Inc. 12.16M shares

#3 MORGAN STANLEY 10.43M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest44.01M

Days to Cover12.0

% of Float32.8%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

8-K 8K EVENT 2026-04-30

424B5 ATM 2026-04-29

424B5 ATM 2026-04-27

4 INSIDER TRANSACTION 2026-03-03

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual NTLA Dilution Snapshot

Intellia Therapeutics, Inc. (NTLA) has a DilutionScore of 54/100, rated High dilution risk. Score date: August 28, 2026.

Stored ATM program remaining capacity: $180.0M.
Recent SEC activity tracked for NTLA: 8-K on 2026-04-30; 424B5 on 2026-04-29; 424B5 on 2026-04-27.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.